Neurocrine Biosciences (NBIX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Neurocrine Biosciences (NBIX)

An SI Board Since July 1996

Posts	SubjectMarks	Bans	Symbol
1834	74	0	NBIX

Emcee: Billy Dunn	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
934	>> laying a little chemistry on y'all << and, unfortunately, ri	scaram(o)uche	-	5/14/2002
933	<i>Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.	keokalani'nui	-	5/14/2002
932	Early concern about 34060 patent protection expiration in "03 is evaporatin	Miljenko Zuanic	-	5/14/2002
931	>> my view that the Sterling report generally is a bunch of hooey <&l	scaram(o)uche	-	5/13/2002
930	Jim, I'm sure you had the following in mind. (You would probably get a fas	keokalani'nui	-	5/8/2002
929	Does anyone know where MRK may stand in the clinic for this mechanism? They hav	Biotech Jim	-	5/7/2002
928	Tuesday May 7, 7:31 am Eastern Time Press Release SOURCE: Neurocrine Biosciences	IRWIN JAMES FRANKEL	-	5/7/2002
927	Note that the CEPH drug modafinil (Provigil) specifically activates the orexin-s	Biotech Jim	-	5/4/2002
926	Nature Reviews Neuroscience 3, 339 -349 (2002) THE HYPOCRETINS: SETTING THE A	Miljenko Zuanic	-	5/3/2002
925	>> I think that the BT Investing Threads should be renamed the CALVINIST t	scaram(o)uche	-	5/1/2002
924	-:) I think we're all coming down with something, something ugly. From the	quidditch	-	5/1/2002
923	Thought that was only a UK accounting convention. Is it also GAAP in the US? H	keokalani'nui	-	5/1/2002
922	<"We are pleased to be extending our collaboration with Wyeth based on t	quidditch	-	5/1/2002
921	Wednesday May 1, 7:30 am Eastern Time Press Release SOURCE: Neurocrine Bioscienc	scaram(o)uche	-	5/1/2002
920	I guess I am haunting you today. Without looking at the 10K, I would guess that	quidditch	-	5/1/2002
919	Have to admit I am baffled. How can it be that the FYE number of a company'	keokalani'nui	-	5/1/2002
918	Neurocrine Biosciences Reports First Quarter 2002 Results SAN DIEGO, April 29 /	mopgcw	-	4/30/2002
917	Message 17401169 The same here.	Miljenko Zuanic	-	4/29/2002
916	Market cap 2x cash (eom).	keokalani'nui	-	4/29/2002
915	My internal response to reading that was along the old line of no %&&$ s	mopgcw	-	4/17/2002
914	>> In our view, given the stage of development for Neurocrine, quarterly e	scaram(o)uche	-	4/17/2002
913	Thanks Geogre. <<We estimate that NBI-34060 will likely be launched in bo	Miljenko Zuanic	-	4/17/2002
912	SSB Part II: As a reminder, on July 17, 2001, Neurocrine announced positive res	mopgcw	-	4/17/2002
911	SSB from 2/5/02 Part 1: Neurocrine Biosciences (NBIX)# NBIX: Reports Financial	mopgcw	-	4/17/2002
910	It is actually part of the Q1 earnings preview of about dozen or so companies, t	mopgcw	-	4/17/2002

Go to reply# or date (mm/dd/yy):